"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
NCT ID: NCT01408771
Last Updated: 2011-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2011-04-30
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of Life
NCT07044778
The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder
NCT00553657
Overactive Bladder (OAB) Drink Advice Study
NCT00982241
Urge Incontinence Bladder Overactivity Study
NCT00475696
Experience Sampling Method in OAB Patients
NCT03435991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* antimuscarinic medications were requested to stop for 7 days before the cystometry
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assaf-Harofeh Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kobi Stav, MD
Role: PRINCIPAL_INVESTIGATOR
Assaf Harofeh Medical Center, Zeriffin, Israel
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.